Head and Neck Cancer (H&N)
Conditions
Keywords
Head and Neck Cancer (H&N), far infrared, transcutaneous electrical nerve stimulation
Brief summary
The goal of this clinical trial is to determine whether far-infrared therapy and transcutaneous electrical nerve stimulation (TENS) can improve postoperative side effects in patients with head and neck cancer. The main questions this study aims to answer are: Can far-infrared therapy and transcutaneous electrical nerve stimulation reduce pain and improve neck range of motion? Can far-infrared therapy and transcutaneous electrical nerve stimulation reduce inflammation? Researchers will compare three groups: Group A: control group; Group B: transcutaneous electrical nerve stimulation; Group C: far-infrared therapy combined with transcutaneous electrical nerve stimulation, to evaluate differences in pain, neck range of motion, and inflammation. Participants will receive the assigned intervention in the morning and evening for five consecutive days. Outcome measurements will be conducted on the first and fifth days.
Interventions
DEVICETranscutaneous Electrical Nerve Stimulation (TENS)
Transcutaneous electrical nerve stimulation is applied to the neck region twice daily, in the morning and evening, for five consecutive days.
DEVICEFar-Infrared Therapy
Far-infrared therapy is applied to the neck region twice daily, in the morning and evening, for five consecutive days.
Sponsors
Buddhist Tzu Chi General Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
30 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
1. Patients aged 30 to 85 years with a confirmed diagnosis of head and neck cancer. 2. Patients scheduled to undergo surgical resection. 3. Patients who are conscious, able to communicate verbally or in writing, and willing to complete questionnaires and comply with all study procedures.
Exclusion criteria
1. Presence of open wounds or skin lesions at the sites where transcutaneous acupoint electrical stimulation electrodes would be applied. 2. Contraindications to transcutaneous acupoint electrical stimulation, including a history of epilepsy, brain tumors, arteriovenous malformations, or implanted cardiac pacemakers or defibrillators, to avoid potential adverse effects of electrical stimulation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Pain intensity | Preoperative baseline (before surgery), postoperative day 10, and postoperative day 15 | Pain intensity will be assessed using a numeric rating scale (NRS), with scores ranging from 0 (no pain) to 10 (worst pain imaginable). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Neck range of motion (ROM) | Preoperative baseline (before surgery), postoperative day 10, and postoperative day 15 | Active neck range of motion will be measured in degrees, including flexion, extension, bilateral rotation, and bilateral lateral flexion. |
| Inflammatory markers (LMR, NLR) | Preoperative baseline (before surgery), postoperative day 10, and postoperative day 15 | Inflammatory markers will be calculated from complete blood counts, including the Lymphocyte-to-monocyte ratio(LMR) and neutrophil-to-lymphocyte ratio (NLR) |
Countries
Taiwan
Outcome results
None listed